Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 8,460.00
-290.00 (-3.31%)
At close: Mar 19, 2026
242.51% (1Y)
| Market Cap | 312.64B +246.2% |
| Revenue (ttm) | 25.95B +7.7% |
| Net Income | -27.82B |
| EPS | -693.34 |
| Shares Out | 34.89M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 619,388 |
| Average Volume | 668,495 |
| Open | 8,690.00 |
| Previous Close | 8,750.00 |
| Day's Range | 8,380.00 - 9,000.00 |
| 52-Week Range | 2,170.00 - 10,180.00 |
| Beta | 0.92 |
| RSI | 60.65 |
| Earnings Date | Nov 14, 2025 |